Samsung Pharmaceutical Co., Ltd.
2 clinical trials · Sponsor
◉ Watch Samsung Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| GV1001 Subcutaneous for the Treatment of Moderate to Severe Alzheimer's Disease(AD) (NCT05303701) | Samsung Pharmaceutical Co., Ltd. | 2027-07-01 |
| A Phase III Study to Assess the Efficacy and Safety of GV1001-Gem/Cap vs Gem/Cap in Pancreatic Cancer Patients (NCT02854072) | Samsung Pharmaceutical Co., Ltd. | 2015-11-01 |
Track Samsung Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.